Exenatide Once Weekly for Management of Type 2 Diabetes: A Review

Exenatide is one of the exendin-based glucagon-like peptide 1 receptor agonists (GLP-1RAs) and is currently available in two formulations, ie, exenatide twice daily (BID), a short-acting GLP-1RA, and exenatide once weekly (QW), a long-acting GLP-1RA. Clinical efficacy and safety of exenatide 2 mg QW...

Descripción completa

Detalles Bibliográficos
Autores principales: Inaishi, Jun, Saisho, Yoshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004502/
https://www.ncbi.nlm.nih.gov/pubmed/35422660
http://dx.doi.org/10.2147/CPAA.S288846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004502/
https://www.ncbi.nlm.nih.gov/pubmed/35422660
http://dx.doi.org/10.2147/CPAA.S288846

Ejemplares similares